DAFNA Capital Management LLC
CIK 1389933 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $524.4M
- Posisi
- 88
- Per tanggal
- 30 Juni 2026
#3.663 dari 9.443 berdasarkan nilai 13F · top 38.8%
Nilai portofolio QoQ: +19.3% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 56,21%
- Bobot 25 kepemilikan teratas
- 79,78%
- Posisi di atas 1%
- 27
- Jumlah posisi efektif
- 16,4
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 15,79% Perkiraan pembelian $76.086.447 · penjualan $108.771.659
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 65,7% masih dipegang
- Posisi baru
- 17
- Meningkat
- 17
- Menurun
- 26
- Tertutup
- 11
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +113.9% · S&P 500: +17.7%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 88,2% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
83,9%
Lainnya/Tidak terpetakan
16,1%
Portofolio lengkap 88 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. - Common Stock | $105.369.346 | 20,09% | 562.630 | $48.898.410 | Turun ×4 | ||
| XBI XBI | $31.096.916 | 5,93% | 196.505 | $-9.585.728 | Turun ×4 | ||
| CMPS COMPASS Pathways Plc - American Depository Shares | $28.469.121 | 5,43% | 2.011.952 | $15.092.704 | Turun ×1 | ||
| STXS | $23.530.553 | 4,49% | 13.680.554 | $-1.641.666 | |||
| NKTR Nektar Therapeutics - Common Stock | $22.226.108 | 4,24% | 318.380 | $10.341.551 | Naik ×4 | ||
| DNLI Denali Therapeutics Inc. - Common Stock | $19.007.440 | 3,62% | 739.014 | $12.892.240 | Naik ×1 | ||
| IDYA IDEAYA Biosciences, Inc. - Common Stock | $18.532.135 | 3,53% | 497.240 | $2.647.158 | Naik ×1 | ||
| ATRC AtriCure, Inc. - Common Stock | $16.716.119 | 3,19% | 597.431 | $-328.587 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $15.136.598 | 2,89% | 250.772 | $554.206 | |||
| CYTK Cytokinetics, Incorporated - Common Stock | $14.652.510 | 2,79% | 171.998 | $317.283 | Turun ×4 | ||
| RCUS Arcus Biosciences, Inc. Common Stock | $13.621.588 | 2,60% | 441.829 | $4.034.882 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: K08588103) | $12.927.652 | 2,47% | 48.469 | Naik ×1 | |||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $9.736.098 | 1,86% | 57.769 | $433.278 | Turun ×1 | ||
| AXGN Axogen, Inc. - Common Stock | $9.651.862 | 1,84% | 208.960 | $1.370.687 | Turun ×3 | ||
| PODD Insulet Corporation - Common Stock | $9.419.708 | 1,80% | 61.870 | $7.138.747 | Naik ×2 | ||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $9.215.656 | 1,76% | 226.819 | $5.680.222 | Naik ×1 | ||
| BCAX Bicara Therapeutics Inc. - Common Stock | $8.460.314 | 1,61% | 284.955 | $72.045 | Turun ×1 | ||
| IBB IBB | $8.101.143 | 1,54% | 42.595 | $-2.383.598 | Turun ×3 | ||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $7.328.674 | 1,40% | 335.255 | $2.251.261 | Naik ×1 | ||
| MPLT MapLight Therapeutics, Inc. - Common Stock | $6.128.855 | 1,17% | 171.006 | $2.652.303 | |||
| LRMR Larimar Therapeutics, Inc. - Common Stock | $6.124.900 | 1,17% | 2.008.164 | $-3.006.338 | Turun ×1 | ||
| IPSC Century Therapeutics, Inc. - Common Stock | $5.881.122 | 1,12% | 2.400.458 | $379.484 | Turun ×2 | ||
| DXCM DexCom, Inc. - Common Stock | $5.810.891 | 1,11% | 86.279 | $392.570 | |||
| IMVT Immunovant, Inc. - Common Stock | $5.761.160 | 1,10% | 149.524 | $2.022.144 | Turun ×1 | ||
| INGN Inogen, Inc - Common Stock | $5.451.405 | 1,04% | 845.179 | $228.199 | |||
| TNDM Tandem Diabetes Care, Inc. - Common Stock | $5.360.089 | 1,02% | 355.208 | $-1.449.248 | |||
| ALKS Alkermes plc - Ordinary Shares | $5.305.832 | 1,01% | 101.266 | $373.748 | Turun ×1 | ||
| STOK Stoke Therapeutics, Inc. - Common Stock | $4.282.230 | 0,82% | 130.875 | $20.940 | |||
| ALLO Allogene Therapeutics, Inc. - Common Stock | $4.160.000 | 0,79% | 2.000.000 | $816.912 | Naik ×1 | ||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $4.002.480 | 0,76% | 400.248 | $-93.481 | Turun ×1 | ||
| GLPG Galapagos NV - American Depositary Shares | $3.902.647 | 0,74% | 130.175 | $-2.603 | |||
| KIDS OrthoPediatrics Corp. - Common Stock | $3.618.057 | 0,69% | 189.130 | $2.099.949 | Naik ×1 | ||
| HELP Cybin Inc. - Common Stock | $3.397.943 | 0,65% | 514.061 | $1.005.810 | Naik ×2 | ||
| RAPP Rapport Therapeutics, Inc. - Common Stock | $3.125.250 | 0,60% | 75.000 | $778.500 | |||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $3.096.090 | 0,59% | 27.000 | Naik ×1 | |||
| PRQR ProQR Therapeutics N.V. - Ordinary Shares | $2.846.471 | 0,54% | 1.530.361 | $307.022 | Turun ×1 | ||
| NGNE Neurogene Inc. - Common Stock | $2.800.056 | 0,53% | 89.032 | $1.658.294 | Naik ×2 | ||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $2.754.860 | 0,53% | 239.553 | Naik ×1 | |||
| PRCT PROCEPT BioRobotics Corporation - Common Stock | $2.709.600 | 0,52% | 120.000 | $-291.600 | |||
| AQST Aquestive Therapeutics, Inc. - Common Stock | $2.687.006 | 0,51% | 645.915 | $1.158.084 | Naik ×1 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $2.549.555 | 0,49% | 68.518 | $376.164 | |||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $2.495.655 | 0,48% | 46.500 | $254.355 | |||
| ALGN Align Technology, Inc. - Common Stock | $2.361.240 | 0,45% | 14.000 | $-210.210 | Turun ×2 | ||
| VKTX Viking Therapeutics, Inc. - Common Stock | $2.321.719 | 0,44% | 59.516 | $385.068 | |||
| NGEN NervGen Pharma Corp. - Common stock | $2.163.000 | 0,41% | 1.050.000 | Naik ×1 | |||
| BHVN Biohaven Ltd. Common Shares | $2.047.384 | 0,39% | 137.593 | $-5.107.534 | Turun ×2 | ||
| MAZE Maze Therapeutics, Inc. - Common Stock | $1.939.600 | 0,37% | 65.000 | $894.850 | Naik ×1 | ||
| ALEC Alector, Inc. - Common Stock | $1.825.786 | 0,35% | 908.351 | $-127.169 | |||
| LXEO Lexeo Therapeutics, Inc. - Common Stock | $1.755.210 | 0,33% | 377.059 | $-409.109 | |||
| PROF Profound Medical Corp. - common stock | $1.731.394 | 0,33% | 260.360 | $27.122 | Turun ×2 | ||
| Penerbit tidak dikenal (CUSIP: 04965N104) | $1.721.600 | 0,33% | 128.000 | Naik ×1 | |||
| ANNX Annexon, Inc. - common stock | $1.700.507 | 0,32% | 297.812 | $1.047.829 | Naik ×1 | ||
| CTMX CytomX Therapeutics, Inc. - Common Stock | $1.644.026 | 0,31% | 438.407 | $563.026 | Naik ×1 | ||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $1.572.669 | 0,30% | 47.100 | $292.624 | Turun ×1 | ||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $1.491.216 | 0,28% | 225.600 | Naik ×1 | |||
| DSGN Design Therapeutics, Inc. - Common Stock | $1.484.622 | 0,28% | 102.600 | Naik ×1 | |||
| FATE Fate Therapeutics, Inc. - Common Stock | $1.417.500 | 0,27% | 525.000 | $757.500 | Turun ×1 | ||
| MDWD MediWound Ltd. - Ordinary Shares | $1.387.754 | 0,26% | 94.405 | $-133.111 | |||
| KURA Kura Oncology, Inc. - Common Stock | $1.322.631 | 0,25% | 120.568 | $-594.976 | Turun ×1 | ||
| SPRY ARS Pharmaceuticals, Inc. - Common Stock | $1.315.923 | 0,25% | 164.285 | $197.464 | Naik ×1 | ||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $1.200.340 | 0,23% | 44.490 | $157.646 | Naik ×1 | ||
| IMTX Immatics N.V. - Ordinary Shares | $1.184.805 | 0,23% | 116.960 | $-1.037.657 | Turun ×2 | ||
| TELA TELA Bio, Inc. - Common stock | $1.080.772 | 0,21% | 1.441.029 | $187.334 | |||
| PYPD PolyPid Ltd. - Ordinary Shares | $1.056.132 | 0,20% | 207.900 | $145.530 | |||
| CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $1.010.911 | 0,19% | 107.773 | Naik ×1 | |||
| INSP Inspire Medical Systems, Inc. Common Stock | $811.902 | 0,15% | 18.200 | $-126.854 | |||
| ACET Adicet Bio, Inc. - Common Stock | $810.536 | 0,15% | 93.812 | $171.676 | |||
| Penerbit tidak dikenal (CUSIP: 81221K108) | $703.728 | 0,13% | 32.400 | Naik ×1 | |||
| MBX MBX Biosciences, Inc. - Common Stock | $651.857 | 0,12% | 11.809 | $-4.585.773 | Turun ×1 | ||
| BNTX BioNTech SE - American Depositary Shares | $651.350 | 0,12% | 7.000 | $29.190 | |||
| ARTV Artiva Biotherapeutics, Inc. - Common Stock | $650.880 | 0,12% | 67.101 | Naik ×1 | |||
| PLRX Pliant Therapeutics, Inc. - Common Stock | $555.180 | 0,11% | 487.000 | $-58.440 | |||
| Penerbit tidak dikenal (CUSIP: 811292309) | $552.983 | 0,11% | 135.868 | Naik ×1 | |||
| EDIT Editas Medicine, Inc. - Common Stock | $552.323 | 0,11% | 170.470 | Naik ×1 | |||
| OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | $547.319 | 0,10% | 126.841 | $8.245 | |||
| FHTX Foghorn Therapeutics Inc. - Common Stock | $545.872 | 0,10% | 111.859 | $11.186 | |||
| ARAY Accuray Incorporated - Common Stock | $433.235 | 0,08% | 1.680.508 | $-218.970 | |||
| QTTB Q32 Bio Inc. - Common Stock | $419.095 | 0,08% | 32.896 | Naik ×1 | |||
| NVCT Nuvectis Pharma, Inc. - Common Stock | $367.800 | 0,07% | 20.000 | Naik ×1 | |||
| CGEN Compugen Ltd. - Ordinary Shares | $360.016 | 0,07% | 168.232 | $-189.062 | Turun ×2 | ||
| IBIO iBio, Inc. - Common Stock | $297.593 | 0,06% | 170.053 | $-70.319 | Turun ×1 | ||
| AUTL Autolus Therapeutics plc - American Depositary Shares | $286.906 | 0,05% | 179.316 | $39.450 | |||
| BCYC Bicycle Therapeutics plc - American Depositary Shares | $273.446 | 0,05% | 64.492 | $-25.797 | |||
| TNYA Tenaya Therapeutics, Inc. - Common Stock | $221.730 | 0,04% | 300.000 | ||||
| VRCA Verrica Pharmaceuticals Inc. - Common Stock | $145.350 | 0,03% | 23.750 | $-667.786 | Turun ×2 | ||
| Penerbit tidak dikenal (CUSIP: 29286X101) | $129.145 | 0,02% | 74.650 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 485925101) | $119.250 | 0,02% | 5.000 | Naik ×1 | |||
| ADCT ADC Therapeutics SA Common Shares | $82.477 | 0,02% | 77.081 | $-187.827 | Naik ×1 | ||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
| Sekuritas | Nilai | % dari portofolio | Rentetan |
|---|---|---|---|
| NKTR | $22.226.108 | 4,24% | naik ×4 |
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| Penerbit tidak dikenal (CUSIP: K08588103) | $12.927.652 | 48.469 | 2,47% |
| KYMR | $3.096.090 | 27.000 | 0,59% |
| ANL | $2.754.860 | 239.553 | 0,53% |
| NGEN | $2.163.000 | 1.050.000 | 0,41% |
| Penerbit tidak dikenal (CUSIP: 04965N104) | $1.721.600 | 128.000 | 0,33% |
| EPRX | $1.491.216 | 225.600 | 0,28% |
| DSGN | $1.484.622 | 102.600 | 0,28% |
| CRBP | $1.010.911 | 107.773 | 0,19% |
| Penerbit tidak dikenal (CUSIP: 81221K108) | $703.728 | 32.400 | 0,13% |
| ARTV | $650.880 | 67.101 | 0,12% |
| Penerbit tidak dikenal (CUSIP: 811292309) | $552.983 | 135.868 | 0,11% |
| EDIT | $552.323 | 170.470 | 0,11% |
| QTTB | $419.095 | 32.896 | 0,08% |
| NVCT | $367.800 | 20.000 | 0,07% |
| TNYA | $221.730 | 300.000 | 0,04% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| RVMD | Dipangkas | -18K | +$48.9M |
| CMPS | Dipangkas | -407K | +$15.1M |
| DNLI | Beli lebih banyak | +421K | +$12.9M |
| NKTR | Beli lebih banyak | +153K | +$10.3M |
| XBI | Dipangkas | -122K | -$9.6M |
| PODD | Beli lebih banyak | +51K | +$7.1M |
| EWTX | Beli lebih banyak | +115K | +$5.7M |
| BHVN | Dipangkas | -708K | -$5.1M |
| RCUS | Dipangkas | -2K | +$4.0M |
| LRMR | Dipangkas | -21K | -$3.0M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| BPMC | 30 Sep. 2025 | 168.763 | $21.632.041 | Tidak lagi dilacak |
| DAWN | 30 Juni 2026 | 978.463 | $20.978.247 | Tidak lagi dilacak |
| MRUS | 31 Des. 2025 | 220.451 | $20.755.462 | Tidak lagi dilacak |
| KALV | 30 Juni 2026 | 267.402 | $5.382.802 | Tidak lagi dilacak |
| ASND | 30 Juni 2026 | 23.177 | $5.301.275 | -2,8% |
| ATXS | 31 Maret 2026 | 304.775 | $3.989.505 | Tidak lagi dilacak |
| SLNO | 31 Des. 2025 | 53.000 | $3.582.800 | Tidak lagi dilacak |
| CMPX | 31 Des. 2025 | 946.661 | $3.313.314 | -54,4% |
| KRRO | 31 Des. 2025 | 60.804 | $2.911.904 | 68,7% |
| TSVT | 30 Juni 2025 | 429.252 | $2.120.505 | Tidak lagi dilacak |
| FULC | 30 Juni 2026 | 205.000 | $1.572.350 | 5,7% |
| RGLS | 30 Juni 2025 | 847.176 | $1.482.558 | Tidak lagi dilacak |
| ITOS | 30 Sep. 2025 | 140.847 | $1.404.245 | Tidak lagi dilacak |
| KROS | 31 Des. 2025 | 80.716 | $1.276.927 | -47,1% |
| ENGN | 30 Juni 2026 | 187.353 | $1.275.874 | 4,3% |
| SPRY | 30 Juni 2025 | 95.290 | $1.198.748 | -64,9% |
| BDTX | 31 Des. 2025 | 307.070 | $1.163.795 | -11,5% |
| LCTX | 30 Juni 2025 | 2.511.374 | $1.134.136 | Tidak lagi dilacak |
| VYNE | 30 Sep. 2025 | 636.103 | $1.049.570 | Tidak lagi dilacak |
| GOSS | 30 Sep. 2025 | 849.921 | $1.045.403 | -94,1% |
| SCYX | 30 Juni 2026 | 1.086.956 | $996.630 | 29,2% |
| PVLA | 30 Sep. 2025 | 43.348 | $977.064 | 130,1% |
| ERAS | 31 Maret 2026 | 254.436 | $946.502 | 8,2% |
| ORIC | 30 Juni 2026 | 98.724 | $945.460 | 32,2% |
| SAGE | 30 Juni 2025 | 108.200 | $860.190 | Tidak lagi dilacak |
| ZBIO | 30 Juni 2026 | 42.500 | $830.875 | 17,8% |
| CNTA | 31 Maret 2025 | 47.453 | $794.838 | Tidak lagi dilacak |
| VIR | 31 Maret 2025 | 100.000 | $734.000 | 46,3% |
| TSHA | 30 Juni 2025 | 522.500 | $726.275 | 164,1% |
| ACRV | 31 Maret 2025 | 112.414 | $676.732 | 9,4% |
| NAMS | 30 Juni 2026 | 20.000 | $640.200 | -17,5% |
| URGN | 31 Des. 2025 | 27.515 | $548.924 | 109,6% |
| MASI | 31 Maret 2025 | 3.000 | $495.900 | Tidak lagi dilacak |
| CRDF | 30 Juni 2025 | 150.000 | $471.000 | -71,5% |
| CATX | 31 Maret 2025 | 130.169 | $415.239 | Tidak lagi dilacak |
| STRO | 31 Des. 2025 | 437.079 | $379.559 | 82,8% |
| ACET | 30 Sep. 2025 | 540.000 | $329.400 | 1090,9% |
| SLRN | 31 Maret 2025 | 87.989 | $276.285 | Tidak lagi dilacak |
| KPTI | 30 Juni 2026 | 45.800 | $255.106 | -80,3% |
| BWAY | 31 Maret 2026 | 12.965 | $246.594 | 14,7% |
| CMPX | 31 Maret 2025 | 158.394 | $229.671 | 28,9% |
| NVRO | 30 Juni 2025 | 38.000 | $221.920 | Tidak lagi dilacak |
| PHGE | 31 Des. 2025 | 401.136 | $210.596 | Tidak lagi dilacak |
| APRE | 31 Des. 2025 | 137.174 | $202.332 | -21,2% |
| PRCT | 30 Sep. 2025 | 3.000 | $172.800 | -39,3% |
| IFRX | 30 Sep. 2025 | 200.000 | $158.000 | 58,2% |
| CATX | 31 Maret 2026 | 50.000 | $137.500 | Tidak lagi dilacak |
| NMRA | 30 Juni 2026 | 70.000 | $136.500 | -6,5% |
| SPRO | 30 Juni 2025 | 125.000 | $90.000 | -56,9% |
| TNYA | 30 Juni 2025 | 47.319 | $26.977 | 17,6% |